TAC1 and respiratory depression: Dexmedetomidine is a selective α-2 agonist that induces sedation by reducing sympathetic outflow and provides analgesia by inhibiting substance P; it offers advantages over benzodiazepines and opioids by providing sedation and analgesia with minimal respiratory depression and greater hemodynamic stability.